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a b s t r a c t
A case of chromoblastomycosis of the hand caused by Rhinocladiella aquaspersa is described. The case
was acquired locally in tropical Venezuela and was successfully treated with oral itraconazole.
& 2013 The Authors. Published by Elsevier B.V on behalf of International Society for Human and Animal
Mycology All rights reserved.
1. Introduction
Chromoblastomycosis is a chronic granulomatous fungal infec-
tion that causes hyperproliferation of cutaneous and subcutaneous
tissues and is histologically characterized by the presence of
muriform cells. Infection originates after the etiologic agent gains
entrance via percutaneous trauma [1]. Main agents responsible
for its etiology are Fonsecaea pedrosoi, Fonsecaea monophora,
Cladophialophora carrionii, Phialophora verrucosa, and Rhinocladiella
aquaspersa. The disease is found in tropical and subtropical areas
[2–4], with the vicarious agents [5] of Fonsecaea and Phialophora
occurring under hot and humid conditions [6], and Cladophialo-
phora being restricted to arid climates [7–10]. R. aquaspersa is an
uncommon cause of chromoblastomycosis, with most cases having
been reported from the American continent [11–14]. The present
paper presents a further case from Venezuela and summarizes the
climatic conditions of the areas where R. aquaspersa is endemic.
2. Case report
A 63-year-old male construction worker, native and resident of a
rural area in Siquisique (Caserío La Unión), Lara State, Venezuela,
presented with an asymptomatic, localized lesion affecting the dorsal
surface of the left hand, involving the knuckles and proximal
interphalangeal joints of the third and fourth ﬁngers. The dermatosis
produced retraction of the ﬁfth ﬁnger. Examination of the skin
disclosed a scaly, crusted, dull-red plaque, friable with hemorrhagic
dots. The lesion was almost ﬂat and eroded. According to the patient,
the lesion had developed over an 18-month period and trauma or
inoculationwas not recalled. There were no lymphatic commitments.
He has never been outside Siquisique city. The patient denied other
problems but was in poor health and nutritional conditions. To
recover the etiologic agent, the area was soaked with alcohol and
scrapings from the lesions were collected into a Petri dish using a
sterile scalpel blade. Direct KOH examination of the crusts of the
lesions revealed numerous thick-walled, globose or ovoidal, dark-
brown muriform cells approximately 68 mm in diameter, either
singly or arranged in groups.
Microscopic examination of a biopsy specimen from the lesion
stained with periodic acid Schiff showed pseudoepitheliomatous
hyperplasia and a mixed cell granulomatous inﬁltrate consisted of
lymphocytes, histiocytes, giant cells, and neutrophils. Muriform
cells were observed in the granulomatous tissue. These results
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conﬁrmed the clinical diagnosis of chromoblastomycosis (Fig. 1).
There were no budding cells, hyphal elements, swollen cells,
pseudohyphal elements, or moniliform hyphae.
Cultures of skin scrapings were performed on Sabouraud's
glucose agar (SGA) with chloramphenicol (0.5 mg/ml). After incu-
bation at 30 1C a slow-growing dark mold was recovered. Micro-
scopically scarce conidia were observed which did not allow
identiﬁcation of the fungus. The isolate was submitted to the
Departamento de Microbiología, Facultad de Medicina, Universi-
dad Autónoma de Nuevo León, Monterrey, Mexico, for morpholo-
gical and molecular identiﬁcation. The patient was treated
with oral itraconazole (100 mg/day).The lesions improved after
2 months, with signiﬁcant healing, desquamations having disap-
peared, and culture became negative. No side effects were noted
by the patient during the course of treatment. Unfortunately, the
patient could not be contacted for further follow-up.
2.1. Mycology
The mold was subcultured on SGA and on potato dextrose agar
(PDA) on culture plates (20 mm diam.) incubated at 30 1C. After
2 weeks velvety colonies developed which were dark olive with an
olivaceous black reverses. Slide cultures were performed on PDA
blocks. After 2 weeks slides were stained with lactophenol cotton
blue and evaluated in a Nikon Eclipse 50i microscope ﬁtted with a
Nikon digital sight DS-2Mv camera. Microscopically brown, sep-
tate hyphae were observed. Conidiophores were erect, 7090 mm
long, unbranched, thick-walled and darkly pigmented, bearing
conidia at their distal portions. Scars were noticed on the con-
idiophores at the sites where conidia had been implanted. Conidia
were single-celled, smooth, ellipsoidal to clavate, 4.06.6 mm
long, light brown. The mold was tentatively identiﬁed by mor-
phology as a Rhinocladiella species.
Carbohydrate assimilation was tested using API 20C AUX
galleries (bioMérieux, Mexico) [15]. Hydrolysis of urea was tested
using Christensen´s urea agar. Inoculated tubes were incubated at
30 1C for 10 days. Cycloheximide tolerance was investigated on
commercial Mycosel agar. Plates were incubated at 30 1C for 10
days. Proteolytic activity was evaluated in gelatin agar slants after
20 days at 30 1C [16]. Thermotolerance was explored with strains
incubated on PDA and Mycosel agar for 2 weeks at 30, 37, and
40 1C [17]. Salt tolerance was investigated in 2% malt extract agar
with 5%, 10%, 17%, and 20% sodium chloride [18]. Plates were
incubated at 30 1C for 20 days.
The isolate assimilated D-glucose, glycerol, 2-k-D-gluconate,
L-arabinose, D-xylose, adonitol, D-galactose, inositol, D-sorbitol,
methyl-D-glucopiranoside, N-acetyl-glucosamine, D-cellobiose,
D-maltose, D-saccharose, D-trehalose, D-melezitose, D-rafﬁnose.
In contrast, D-lactose and xylitol were not assimilated. Urea
hydrolysis was positive, growth on Mycosel agar was not inhibited
by cycloheximide, and liquefaction of gelatin was absent. The
isolate grew at 30 1C, had limited growth at 37 1C, and failed to
grow at 40 1C. Growth in malt extract agar with all sodium chloride
concentrations tested was negative.
For molecular identiﬁcation, approximately 1 cm2 mycelium
from 2-week-old cultures was transferred to 2 ml Eppendorf tubes
containing 200 ml of enzymatic lyses buffer [20 mM Tris–HCl
(pH 8), 2 mM EDTA, 1.2% Triton X-100, 20 mg/ml lysozyme], which
were then incubated at 37 1C for 2 h with agitation. Afterwards,
390 ml TE 1 with 1% SDS and 4 ml (10 mg/ml) proteinase K were
added and cells were incubated for 1 h at 55 1C. After, 100 ml 5 M
NaCl and 80 ml of 10% CTAB/4.1% NaCl were added and the mixture
was vortexed and incubated for 10 min at 65 1C. DNA was
extracted twice with 1 vol of phenol–chloroform–isoamyl alcohol
(25:24:1), precipitated with absolute ethanol, washed with 70%
ethanol, air dried, and resuspended in 200 ml of Tris–EDTA buffer
[19]. Ribosomal DNA ITS domains were ampliﬁed using primers
ITS-4 (5′-TCCTCCGCTTATTGATATGC-3′) and ITS-5 (5′GGAAGTAA
AAGTCGTAACAAGG-3′) [20]. Ampliﬁcations were performed in a
ﬁnal volume of 25 ml containing 1 PCR buffer, 2 mM MgCl2,
0.2 mM of each dNTP, 200 nM of each primer, 1 U of AmpliTaq
polymerase (Bioline, Randolph, MA, U.S.A.) and 100 ng DNA. The
thermocycling conditions were: 94 1C for 4 min, followed by 30
cycles of 94 1C for 60 s, 55 1C for 90 s, and 72 1C for 90 s, with ﬁnal
extension at 72 1C for 5 min. The ﬁnal products were electrophor-
esed in 1.5% agarose gel and stained with ethidium bromide.
Hyper Ladder I (Bioline) was used as a molecular weight marker
for size determinations. The pattern of ampliﬁed bands was
photographed and analyzed with the UVP Biolmaging System,
EpiChemi III Darkroom. PCR products were puriﬁed using the
commercial Wizard PCR Preps DNA puriﬁcation system (Promega,
Madison, WI, U.S.A.). Sequencing was performed in both directions
at the Instituto de Biotecnología, Universidad Nacional Autónoma
de México. DNA sequence fragments were compared to NCBI
GenBank sequence entries using the BLAST algorithm and to
a research database on black fungi at CBS-KNAW Fungal Biodiver-
sity Centre, Utrecht, The Netherlands. The sequence was depo-
sited in GenBank with accession number GU177853 as species of
order Chaetothyriales. Later, the isolate was identiﬁed at CBS as R.
aquaspersa. The culture was deposited in the CBS reference
collection as CBS 132913.
2.2. Antifungal susceptibility
Amphotericin B (AMB) (Bristol-Myers Squibb, Princeton, NJ, U.S.A.),
itraconazole (ITZ) (Janssen Pharmaceutica, Beerse, Belgium), voricona-
zole (VRZ) (Pﬁzer, Inc., New York, NY, U.S.A.), posaconazole (PSZ)
(Schering-Plough, Kenilworth,NJ, U.S.A.), and terbinaﬁne (TBF) (Novar-
tis, Mexico) were obtained in reagent-grade powder form from their
respective manufacturers. Isolates were evaluated by using Clinical
and Laboratory Standard Institute broth macrodilution approved
standard reference method M38-A2 [21]. After adequate sporulation
occurred on PDA, the mycelium was overlaid with sterile distilled
water, and suspensions were made by softly scraping the colonies
with wooden applicators. Heavy fragments were allowed to settle, and
the upper, homogeneous supernatant was transferred to sterile tubes.
Inocula suspension of 106 CFU/ml were prepared by hemacyto-
meter counts and then diluted in RPMI 1640 medium with glutamine
and morpholinopropanesulphonic acid buffer at a concentration of
0.165 M (Angus, Niagara Falls, NY, U.S.A.) to obtain a ﬁnal organism
Fig. 1. Histopathology examination showing cluster of muriform cells stained with
periodic acid Schiff.
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concentration of 0.45104 CFU/ml. The inoculum size for all tests
was veriﬁed by plating 10 ml onto PDA, incubating the plates at 35 1C,
and counting the number of colonies. Serial dilution of the drugs was
made following the CLSI guidelines in order to obtain ﬁnal concentra-
tions of the drugs ranging from 0.015 to 8 mg/L for all antifungal
compounds. Candida krusei ATCC 6258 and Paecilomyces variotii ATCC
MYA3630 were used for quality control.
Results of susceptibility testing were: AMB¼2 mg/ml, TBF¼
0.06 mg/ml, ITZ¼0.125 mg/ml, VRZ¼1 mg/ml, and PSZ¼0.25 mg/ml,
respectively.
3. Discussion
R. aquaspersa is a rare agent of human chromoblastomycosis.
An overview of clinical cases is presented in Table 1; several
reports provided only very scant information. The majority of
historical cases have not been veriﬁed by sequence data, but the
morphology of R. aquaspersa is unmistakable. Most cases report
the presence of muriform cells in tissue, but in Case 3 these were
absent. The clinical appearance of the disease is highly diverse [23].
The main agents of the disease are classiﬁed in Cladophialophora and
Fonsecaea and are restricted to arid and tropical climates, respectively
[5,9], but environmental data of cases of R. aquaspersa do not show
any consistency (Table 1). Caserío La Unión of the present case is
located in the northernmost part of the state, between 600 and
700 m above mean sea level. This area presents temperatures
between 23 and 28 1C, its annual precipitation varies between 950
and 1400 mm, and its annual evaporation rates range from 1400 to
2400 mm. The predominance of semi-deciduous vegetation is asso-
ciated to the aforementioned climatic conditions. The global distribu-
tion of R. aquaspersa is (sub)tropical. The species has thus far not
been recovered from the environment, but Badali et al. [14] men-
tioned a case acquired by from a cactus thorn suggesting a natural
habitat on living or dead plants. Marques et al. [13] reported a case
secondary to an insect bite.
The species is susceptible to commonly used azoles, and in our
case treatment of the infection with itraconazole led to healing
within two months.
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